r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

DR

David M. Rubenstein

Insider · Director · CG

David M. Rubenstein files insider transactions with the SEC as a director of Carlyle Group. We hold 2 disclosed purchases and sales filed since 3 January 2020, 1 of them in the last 90 days.

  • Files for 2 companiesCG, MRNA
  • Disclosed buys and sells2 in all, 1 in the last 90 days
  • Last disclosure11 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 January 2020 — 11 September 2026Director · Carlyle Group 20 Form 4 lines · source: SEC Form 4
  • Filed 5 August 2024 — 6 May 2026Director · Moderna 14 Form 4 lines · source: SEC Form 4

Every transaction

34 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
34 of 34 shown
11 Sep 202611 Sep 2026SEC Form 40 dgave awaynot a tradeCarlyle Group100,000 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dsold on the open marketCarlyle Group400,000 sharesup +0.0%up +0.0%
6 May 20268 May 2026SEC Form 42 dwas grantednot a tradeModernaderivative9,681 sharesup +195.1%up +164.9%
6 May 20268 May 2026SEC Form 42 dwas grantednot a tradeModernaderivative2,092 sharesup +195.1%up +164.9%
30 Apr 20264 May 2026SEC Form 44 dexercised options overnot a tradeModerna8,116 sharesup +213.4%up +204.4%
30 Apr 20264 May 2026SEC Form 44 dexercised options overnot a tradeModernaderivative8,116 sharesup +213.4%up +204.4%
19 Mar 202620 Mar 2026SEC Form 41 dgave awaynot a tradeCarlyle Group100,000 sharesdown −11.3%down −10.2%
19 Mar 202620 Mar 2026SEC Form 41 dsold on the open marketCarlyle Group500,000 sharesdown −11.3%down −10.2%
19 Mar 202620 Mar 2026SEC Form 41 dgave awaynot a tradeCarlyle Group100,000 sharesdown −11.3%down −10.2%
19 Mar 202620 Mar 2026SEC Form 41 dsold on the open marketCarlyle Group500,000 sharesdown −11.3%down −10.2%
10 Dec 202512 Dec 2025SEC Form 42 dgave awaynot a tradeCarlyle Group625,000 sharesdown −29.1%down −27.4%
10 Dec 202512 Dec 2025SEC Form 42 dsold on the open marketCarlyle Group625,000 sharesdown −29.1%down −27.4%
5 Aug 20256 Aug 2025SEC Form 41 dexercised options overnot a tradeModernaderivative850 sharesup +424.1%up +439.0%
5 Aug 20256 Aug 2025SEC Form 41 dexercised options overnot a tradeModerna850 sharesup +424.1%up +439.0%
30 Apr 20251 May 2025SEC Form 41 dexercised options overnot a tradeModernaderivative677 sharesup +404.4%up +432.6%
30 Apr 20251 May 2025SEC Form 41 dwas grantednot a tradeModernaderivative12,756 sharesup +404.4%up +432.6%
30 Apr 20251 May 2025SEC Form 41 dwas grantednot a tradeModernaderivative8,116 sharesup +404.4%up +432.6%
30 Apr 20251 May 2025SEC Form 41 dexercised options overnot a tradeModerna677 sharesup +404.4%up +432.6%
5 Aug 20247 Aug 2024SEC Form 42 dwas grantednot a tradeModernaderivative5,051 sharesup +71.9%up +76.5%
5 Aug 20247 Aug 2024SEC Form 42 dwas grantednot a tradeModernaderivative4,065 sharesup +71.9%up +76.5%
5 Aug 20247 Aug 2024SEC Form 42 dwas grantednot a tradeModernaderivative850 sharesup +71.9%up +76.5%
5 Aug 20247 Aug 2024SEC Form 42 dwas grantednot a tradeModernaderivative677 sharesup +71.9%up +76.5%
6 Jun 20226 Jun 2022SEC Form 40 dsold on the open marketCarlyle Group2,000,000 sharesup +6.2%up +6.2%
9 Nov 202110 Nov 2021SEC Form 41 dsold on the open marketCarlyle Group2,000,000 sharesdown −28.8%down −27.0%
13 Aug 202113 Aug 2021SEC Form 40 dsold on the open marketCarlyle Group1,895,200 sharesdown −13.2%down −13.2%
13 Aug 202113 Aug 2021SEC Form 40 dsold on the open marketCarlyle Group4,800 sharesdown −13.2%down −13.2%
11 Aug 202113 Aug 2021SEC Form 42 dsold on the open marketCarlyle Group2,100,000 sharesdown −11.0%down −13.2%
18 May 202119 May 2021SEC Form 41 dsold on the open marketCarlyle Group2,000,000 sharesdown −0.7%up +0.7%
11 Mar 202112 Mar 2021SEC Form 41 dsold on the open marketCarlyle Group3,000,000 sharesup +15.1%up +15.8%
10 Dec 202011 Dec 2020SEC Form 41 dsold on the open marketCarlyle Group750,000 sharesup +42.5%up +42.8%
24 Nov 202024 Nov 2020SEC Form 40 dsold on the open marketCarlyle Group2,000,000 sharesup +47.5%up +47.5%
9 Nov 202010 Nov 2020SEC Form 41 dsold on the open marketCarlyle Group2,000,000 sharesup +53.1%up +51.3%
1 Jan 20203 Jan 2020SEC Form 42 dconvertednot a tradeCarlyle Groupderivative46,999,644 sharesup +32.0%up +34.6%
1 Jan 20203 Jan 2020SEC Form 42 dconvertednot a tradeCarlyle Group46,999,644 sharesup +32.0%up +34.6%

Both percentages are the stock’s move, not David M. Rubenstein’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 34 of the 34 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.